Deuterated Paroxetine

氘代帕罗西汀

Report date: 2025/02/28 11:25:47
NME

Base Information

Drug NameDeuterated Paroxetine
Drug Alias Name氘代帕罗西汀CTP-347
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsSerotonin transporterNorepinephrine transporter
Therapy Area/IndicationsDepressionHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesConcert Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRadboud University Medical Center
Active IndicationsN/A
Inactive IndicationsDepressionHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A